Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1997-4-8
|
pubmed:abstractText |
Pseudotumor cerebri is generally a benign disorder. It has been reported to occur in hypothyroidism, particularly after the initiation of L-thyroxine replacement therapy. Previous case reports have involved children primarily in the peripubertal age range (approximately 8 to 13 years). We report here the development of pseudotumor cerebri in an infant who required treatment with L-thyroxine for transient neonatal hypothyroidism as a result of maternal thyroid-stimulating hormone receptor-blocking antibodies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0022-3476
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
130
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
478-80
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading | |
pubmed:year |
1997
|
pubmed:articleTitle |
Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism.
|
pubmed:affiliation |
Department of Pediatrics, Monteflore Medical Center, Albert Einstein College of Medicine, Bronx, New York 10467, USA.
|
pubmed:publicationType |
Journal Article,
Case Reports
|